• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创食管切除术后的严重并发症会降低局部晚期食管鳞状细胞癌营养状况良好患者的长期预后。

Severe postoperative complications after minimally invasive esophagectomy reduce the long-term prognosis of well-immunonutrition patients with locally advanced esophageal squamous cell carcinoma.

作者信息

Chen Chao, Xu Shao-Jun, Zhang Zhi-Fan, You Cheng-Xiong, Luo Yun-Fan, Chen Rui-Qin, Chen Shu-Chen

机构信息

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.

Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.

出版信息

Ann Med. 2025 Dec;57(1):2440622. doi: 10.1080/07853890.2024.2440622. Epub 2024 Dec 13.

DOI:10.1080/07853890.2024.2440622
PMID:39673205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11648140/
Abstract

BACKGROUND

While severe postoperative complications (SPCs) impact cancer prognosis, their effect on locally advanced esophageal squamous cell carcinoma (ESCC) patients with varying immunonutritional statuses after minimally invasive esophagectomy (MIE) is unclear.

METHODS

This retrospective study analyzed 442 patients with locally advanced ESCC who underwent MIE, investigating the relationship between SPCs and survival based on preoperative immunonutritional status, determined by the prognostic nutritional index (PNI). Nomograms were developed for patients with preserved immunonutritional status using Cox regression, and their performance was assessed.

RESULTS

Of the patients, 102 (23.1%) experienced SPCs after MIE. Five-year overall survival (OS) and disease-free survival (DFS) were significantly different between SPCs and non-SPCs groups ( < 0.001). In the preserved immunonutritional group, SPCs significantly reduced 5-year OS ( = 0.008) and DFS ( = 0.011), but not in the poor immunonutritional group (OS  = 0.152, DFS  = 0.098). Multivariate Cox regression identified SPCs as an independent risk factor for OS (HR = 1.653,  = 0.013) and DFS (HR = 1.476,  = 0.039). A nomogram for predicting OS and DFS in preserved immunonutritional patients demonstrated excellent performance.

CONCLUSIONS

SPCs significantly affect prognosis in ESCC patients with preserved immunonutritional status after MIE. Nomograms based on SPCs can predict OS and DFS in these patients.

摘要

背景

虽然严重术后并发症(SPCs)会影响癌症预后,但它们对微创食管切除术后(MIE)免疫营养状况不同的局部晚期食管鳞状细胞癌(ESCC)患者的影响尚不清楚。

方法

这项回顾性研究分析了442例接受MIE的局部晚期ESCC患者,根据术前免疫营养状况(由预后营养指数(PNI)确定)研究SPCs与生存之间的关系。使用Cox回归为免疫营养状况良好的患者制定列线图,并评估其性能。

结果

在这些患者中,102例(23.1%)在MIE后发生了SPCs。SPCs组和非SPCs组的5年总生存率(OS)和无病生存率(DFS)有显著差异(<0.001)。在免疫营养状况良好的组中,SPCs显著降低了5年OS(=0.008)和DFS(=0.011),但在免疫营养状况较差的组中没有(OS = 0.152,DFS = 0.098)。多因素Cox回归确定SPCs是OS(HR = 1.653,= 0.013)和DFS(HR = 1.476,= 0.039)的独立危险因素。用于预测免疫营养状况良好患者的OS和DFS的列线图表现出色。

结论

SPCs显著影响MIE后免疫营养状况良好的ESCC患者的预后。基于SPCs的列线图可以预测这些患者的OS和DFS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/f3516f43ffef/IANN_A_2440622_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/091cd1820a60/IANN_A_2440622_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/c8f3599f14d8/IANN_A_2440622_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/9579163b3109/IANN_A_2440622_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/db75fa55afaf/IANN_A_2440622_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/f3516f43ffef/IANN_A_2440622_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/091cd1820a60/IANN_A_2440622_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/c8f3599f14d8/IANN_A_2440622_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/9579163b3109/IANN_A_2440622_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/db75fa55afaf/IANN_A_2440622_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f3/11648140/f3516f43ffef/IANN_A_2440622_F0005_C.jpg

相似文献

1
Severe postoperative complications after minimally invasive esophagectomy reduce the long-term prognosis of well-immunonutrition patients with locally advanced esophageal squamous cell carcinoma.微创食管切除术后的严重并发症会降低局部晚期食管鳞状细胞癌营养状况良好患者的长期预后。
Ann Med. 2025 Dec;57(1):2440622. doi: 10.1080/07853890.2024.2440622. Epub 2024 Dec 13.
2
Nomogram for prognosis of patients with esophageal squamous cell cancer after minimally invasive esophagectomy established based on non-textbook outcome.基于非传统预后结果建立的微创食管切除术后食管鳞状细胞癌患者预后列线图。
Surg Endosc. 2022 Nov;36(11):8326-8339. doi: 10.1007/s00464-022-09290-y. Epub 2022 May 12.
3
Impact of minimally invasive total mesoesophageal excision and minimally invasive esophagectomy on failure patterns of locally advanced esophageal squamous cell carcinoma: a matched cohort study with long-term follow-up.微创全食管系膜切除术和微创食管切除术对局部进展期食管鳞癌失败模式的影响:一项长期随访的匹配队列研究。
Surg Endosc. 2023 Oct;37(10):7698-7708. doi: 10.1007/s00464-023-10334-0. Epub 2023 Aug 10.
4
Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy).机器人辅助食管切除术(RAE)与传统微创食管切除术(MIE)治疗可切除的食管鳞癌:一项多中心前瞻性随机对照试验的方案(RAMIE 试验,机器人辅助微创食管切除术)。
BMC Cancer. 2019 Jun 21;19(1):608. doi: 10.1186/s12885-019-5799-6.
5
Inflammatory and Nutritional Status Influences Outcomes of Minimally Invasive Esophagectomy.炎症和营养状况影响微创食管切除术的预后。
World J Surg. 2023 Apr;47(4):1003-1017. doi: 10.1007/s00268-023-06890-0. Epub 2023 Jan 12.
6
The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.神经周围侵犯状态可预测局部晚期食管鳞状细胞癌术后放疗的疗效。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6881-90. eCollection 2015.
7
Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.微创 Ivor Lewis 食管切除术与左开胸食管切除术治疗食管鳞癌的比较:倾向评分匹配分析。
BMC Cancer. 2019 May 27;19(1):500. doi: 10.1186/s12885-019-5656-7.
8
Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.530例接受微创Ivor Lewis食管切除术的食管鳞状细胞癌患者的长期预后
J Surg Oncol. 2018 Apr;117(5):957-969. doi: 10.1002/jso.24997.
9
Minimally Invasive Esophagectomy Provides Better Short- and Long-Term Outcomes Than Open Esophagectomy in Locally Advanced Esophageal Cancer.微创食管切除术在局部晚期食管癌中的短期和长期结果优于开放食管切除术。
Ann Surg Oncol. 2024 Sep;31(9):5748-5756. doi: 10.1245/s10434-024-15596-z. Epub 2024 Jun 19.
10
The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer.微创手术治疗食管癌术后并发症对患者生存的影响。
Surg Endosc. 2017 Sep;31(9):3475-3482. doi: 10.1007/s00464-016-5372-1. Epub 2016 Dec 6.

引用本文的文献

1
Risk factors associated with failure to rescue after minimally invasive Ivor Lewis esophagectomy.微创Ivor Lewis食管切除术后抢救失败的相关危险因素。
Surg Endosc. 2025 Jul 14. doi: 10.1007/s00464-025-11949-1.

本文引用的文献

1
How we treat esophageal squamous cell carcinoma.我们如何治疗食管鳞状细胞癌。
ESMO Open. 2023 Feb;8(1):100789. doi: 10.1016/j.esmoop.2023.100789. Epub 2023 Feb 13.
2
Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment.中性粒细胞与白蛋白比值作为接受手术治疗的结直肠癌患者术后并发症和长期预后的生物标志物。
Front Nutr. 2022 Nov 15;9:976216. doi: 10.3389/fnut.2022.976216. eCollection 2022.
3
Esophageal cancer in China: Practice and research in the new era.
中国食管癌:新时代的实践与研究。
Int J Cancer. 2023 May 1;152(9):1741-1751. doi: 10.1002/ijc.34301. Epub 2022 Oct 5.
4
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients.炎症相关生物标志物预测结直肠癌患者预后。
Int J Mol Sci. 2021 Jul 27;22(15):8002. doi: 10.3390/ijms22158002.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Current status of esophageal cancer treatment.食管癌治疗的现状
Chin J Cancer Res. 2020 Jun;32(3):271-286. doi: 10.21147/j.issn.1000-9604.2020.03.01.
7
Prognostic value of serum inflammatory markers in colorectal cancer.血清炎症标志物在结直肠癌中的预后价值。
Int J Colorectal Dis. 2020 Jul;35(7):1211-1219. doi: 10.1007/s00384-020-03591-1. Epub 2020 Apr 18.
8
Inflammatory response and recurrence after minimally invasive esophagectomy.微创食管切除术后的炎症反应和复发。
Langenbecks Arch Surg. 2019 Sep;404(6):761-769. doi: 10.1007/s00423-019-01818-6. Epub 2019 Aug 30.
9
Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.肺癌手术后严重术后并发症的长期预后影响。
Ann Surg Oncol. 2019 Jan;26(1):230-237. doi: 10.1245/s10434-018-7061-x. Epub 2018 Nov 19.
10
Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.炎症相关评分在接受结直肠癌根治性切除术患者中的预后价值。
BMC Cancer. 2018 Nov 12;18(1):1102. doi: 10.1186/s12885-018-4842-3.